Recombinant factor VII
Ng, S.C.
Medical Journal of Malaysia 50(4): 425
1995
ISSN/ISBN: 0300-5283 PMID: 8668070 Document Number: 441817
Document emailed within 1 workday
Related Documents
Drize, N.; Chertkov, J.; Zander, A. 1995: Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) Experimental Hematology 23(11): 1180-1186Bialas, T.; Kolitz, J.; Levi, E.; Polivka, A.; Oez, S.; Miller, G.; Welte, K. 1988: Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin Cancer Research 48(4): 891-898
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Talmadge, J.E.; Tribble, H.R.; Pennington, R.W.; Phillips, H.; Wiltrout, R.H. 1987: Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice Cancer Research 47(10): 2563-2570
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316
Abbruzzese, J.L.; Levin, B.; Ajani, J.A.; Faintuch, J.S.; Saks, S.; Patt, Y.Z.; Edwards, C.; Ende, K.; Gutterman, J.U. 1989: Phase i trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer Cancer Research 49(14): 4057-4061
Xia, H.Z.; Du, Z.; Craig, S.; Klisch, G.; Noben-Trauth, N.; Kochan, J.P.; Huff, T.H.; Irani, A.M.; Schwartz, L.B. 1997: Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type i expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells Journal of Immunology 159(6): 2911-2921
Kownatzki, E.; Kapp, A.; Uhrich, S. 1988: Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells Clinical and Experimental Immunology 74(1): 143-148
Nissen-Meyer, J.; Austgulen, R.; Espevik, T. 1987: Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity Cancer Research 47(9): 2251-2258
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874
Tusell, J.M. 1993: Recombinant factor VIIi Sangre 38(2): 139-142
White, G.; Shapiro, A.; Ragni, M.; Garzone, P.; Goodfellow, J.; Tubridy, K.; Courter, S. 1998: Clinical evaluation of recombinant factor IX Seminars in Hematology 35(2 Suppl 2: 33-38
Schaub, R.; Garzone, P.; Bouchard, P.; Rup, B.; Keith, J.; Brinkhous, K.; Larsen, G. 1998: Preclinical studies of recombinant factor IX Seminars in Hematology 35(2 Suppl 2: 28-32
Klein, U. 1991: Production and characterization of recombinant factor VIIi Seminars in Hematology 28(2 Suppl 1: 17-21
Grochova, M.; Kalnasova, B.; Firment, J.; Olejarova, I.; Roland, R.; Lazurova, I. 2011: Pulmonary administration of activated recombinant factor VIi Bratislavske Lekarske Listy 112(1): 29-33
Hilgartner, M.W. 1991: The need for recombinant factor VIII: historical background and rationale Seminars in Hematology 28(2 Suppl 1: 6-9
Ewenstein, B.M. 2001: Continuous infusion of recombinant factor VIIa: continue or not? Thrombosis and Haemostasis 86(4): 942-944
Berntorp, E. 1997: Second generation, B-domain deleted recombinant factor VIII Thrombosis and Haemostasis 78(1): 256-260
Fournel, M.A. 1991: Preclinical and in vitro studies of recombinant factor VIIi Seminars in Hematology 28(2 Suppl 1: 22-26